查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医疗仿生学市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按应用、按公司和按地区划分
市场调查报告书
商品编码
1289652

医疗仿生学市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按应用、按公司和按地区划分

Medical Biomimetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Application, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在2023-2027年的预测期内，全球医学仿生学市场预计将出现令人瞩目的增长。主要因素包括慢性病的发生率不断增加，医疗仿生学的应用不断增加，以及技术的广泛发展，这些都遏制了市场的增长。生物仿生学是一个跨学科领域，包括生物学、工程学和化学。它被用于开发生物相容性材料，使医疗保健专家能够监测和治疗慢性疾病。它被用于再生医学、组织工程和药物输送。支持市场增长的其他因素有：研发活动的增加，政府资金的增加，器官衰竭发病率的增加，发达和发展中经济体医疗保健支出的增加，人口老龄化的增加，合併和战略收购的数量增加，预期寿命的增加，以及对假体和植入物需求的增加。

慢性疾病发病率的增加

慢性疾病，如心血管疾病、糖尿病和其他疾病的发生率越来越高，促进了全球市场的增长。由于久坐的生活方式和不健康的饮食选择，人们正在遭受这些疾病的困扰，这推动了市场的增长。例如，根据美国疾病控制和预防中心（CDC）的数据，大约每40秒就有一个美国人死于心脏病发作。据估计，每年有80.5万美国人心脏病发作，其中60.5万是第一次发作。老年人口极易患上骨科疾病、心血管疾病以及神经系统疾病等疾病。因此，增加了医疗生物仿生学市场的增长。根据国家肾脏基金会的数据，在全球范围内，65至74岁的人中有四分之一的女性和五分之一的男性患有慢性肾脏疾病。

生物仿生技术的进步

医疗保健领域的快速进步，如机器人技术、3D打印技术和其他技术，正在推动市场的增长。在纳米技术、组织工程和其他领域越来越多地采用各种创新，预计将创造许多机会，抑制市场增长。采用纳米技术可以帮助发展个性化医疗、器官再生、整形手术和药物输送。例如，在美国，2020年，Veryan Medical公司推出了一种新颖的BioMimics 3D血管支架系统。BioMimics是一个以在临床试验中取得超卓成果为目标的系统。

生物仿生学的应用越来越多

医疗领域对生物仿生学的需求不断增长，推动了市场的增长。这要归功于在牙科、心脏病学、骨科、眼科等各个领域的应用不断增加。生物仿生学被用于治疗各种疾病，如阿尔茨海默病、假肢、器官移植等。此外，医疗行业中无创程序（包括心电图、CT扫描和超声波）中的医用生物仿生技术的应用激增，预计将抑制市场的增长。例如，根据美国政府的数据，在2017年，全国大约进行了34,770例移植手术。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告可提供以下定制选项：

公司信息

  • 对其他市场参与者（最多5家）的详细分析和简介。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球医用生物仿生学市场的影响

第五章：客户的声音

第六章：全球医用仿生学市场展望

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型（心血管、骨科、眼科、牙科、其他）分类
    • 按应用（伤口愈合、组织工程、药物输送、整形外科、其他）分类
    • 按地区分类
    • 按公司分类(2021年)
  • 市场地图

第七章：北美医用生物仿生学市场展望

  • 市场规模和预测
    • 按价值分类
  • 市场份额与预测
    • 按类型
    • 按应用分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第8章：欧洲医用仿生学市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按应用分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太医疗仿生学市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按应用分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美医疗仿生学市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按应用分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲医疗仿生学市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额和预测
    • 按类型
    • 按应用分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 医学仿生学
    • 沙特阿拉伯 医学生物仿生学
    • 阿联酋 医学仿生学
    • 土耳其 医学仿生学
    • 埃及 医学仿生学

第十二章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

  • Wright Medical Group N.V. Abbott Laboratories, Inc.Blatchford Group (Chas. A. Blatchford & Sons Ltd) BioHorizons IPH, Inc.Biomimetics Technology Inc SynTouch Inc.Vandstrom, Inc.Gelesis, Inc.BioTomo Pty.Ltd.）。Hstar技术公司

第十五章：战略建议

简介目录
Product Code: 13008

The global medical biomimetics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing occurrences of chronic diseases, increasing applications of medical biomimetics, and extensive development in technology that are curbing the growth of the market. Biomimetics is an interdisciplinary field that comprises biology, engineering, and chemistry. It is used for the development of biocompatible material, which allows healthcare experts to monitor and treat chronic diseases. It is used for regenerative medicine, tissue engineering, and drug delivery. The other factors supporting the market's growth are, rise in R&D activities, increasing favorable government funding, growing incidences of organ failure, the rising healthcare expenditure in developed and developing economies, rise in aging population base, growing number of mergers and strategic acquisitions, growing life expectancy, and rise in demand for prosthesis and implants.

Increasing Prevalence of Chronic Diseases

The growing occurrences of chronic diseases, such as cardiovascular diseases, diabetes, and others, are bolstering the growth of the market globally. Owing to the sedentary lifestyle and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. For instance, as per the Centers for Disease Control and Prevention (CDC), roughly every 40 seconds, an American die from a heart attack. It is estimated that 805,000 Americans have a heart attack every year, 605,000 of them for the first time. Geriatric populations are highly prone to diseases such as orthopedic diseases, cardiovascular diseases as well as neurological disorders. Thus, increasing the growth of the medical biomimetics market. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe.

Advancements in Biomimetic Technologies

Rapid advancements such as robotics, 3D printing technology, and others in the healthcare sector are surging the growth of the market. The increasing adoption of various innovations in areas of nanotechnology, tissue engineering, and others is expected to create numerous opportunities which curb the market growth. The adoption of nanotechnology can aid in the development of personalized medicine, organ regeneration, plastic surgery, and drug delivery. For instance, in the U.S., in 2020, Veryan Medical launched a novel BioMimics 3D vascular stent system. BioMimics is a system that aims for superb outcomes in clinical trials.

Increasing Applications of Biomimetics

The growing demand for biomimetics in the medical sector is fueling the growth of the market. This is attributed to the increasing application in various fields such as dentistry, cardiology, orthopedics, ophthalmology, and others. Biomimetics is used for the treatment of various diseases, such as Alzheimer, prosthetics, organ transplants, and others. Moreover, an upsurge in the application of medical biomimetics in noninvasive procedures, including ECGs, CT scans, and ultrasound, in the healthcare industry is anticipated to curb the growth in the market. For instance, as per the U.S. government's data, in 2017, approximately 34,770 transplants were conducted in the nation.

Market Segmentation

The global medical biomimetics market is segmented into type, application, and company. Based on type, the market is divided into cardiovascular, orthopedic, ophthalmology, dental, and others. Based on application, the market is divided into wound healing, tissue engineering, drug delivery, plastic surgery, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in the adoption rate of novel technology in the country.

Market Players

Wright Medical Group N.V., Abbott Laboratories, Inc., Blatchford Group (Chas. A. Blatchford & Sons Ltd), BioHorizons IPH, Inc., Biomimetics Technology Inc, SynTouch Inc., Vandstrom, Inc., Gelesis, Inc., BioTomo Pty. Ltd., and Hstar Technologies Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global medical biomimetics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Biomimetics Market, By Type:

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Others

Medical Biomimetics Market, By Application:

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Plastic Surgery
  • Others

Medical Biomimetics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Medical Biomimetics Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Medical Biomimetics Market

5. Voice of Customer

6. Global Medical Biomimetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Cardiovascular, Orthopedic, Ophthalmology, Dental, Others)
    • 6.2.2. By Application (Wound Healing, Tissue Engineering, Drug Delivery, Plastic Surgery, Others)
    • 6.2.3. By Region
    • 6.2.4. By Company (2021)
  • 6.3. Market Map

7. North America Medical Biomimetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Medical Biomimetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Canada Medical Biomimetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Mexico Medical Biomimetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application

8. Europe Medical Biomimetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Medical Biomimetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. Germany Medical Biomimetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. United Kingdom Medical Biomimetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Italy Medical Biomimetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Spain Medical Biomimetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Asia-Pacific Medical Biomimetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Medical Biomimetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. India Medical Biomimetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Japan Medical Biomimetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
    • 9.3.4. South Korea Medical Biomimetics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
    • 9.3.5. Australia Medical Biomimetics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application

10. South America Medical Biomimetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medical Biomimetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Argentina Medical Biomimetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Colombia Medical Biomimetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Middle East and Africa Medical Biomimetics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Medical Biomimetics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
    • 11.3.2. Saudi Arabia Medical Biomimetics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
    • 11.3.3. UAE Medical Biomimetics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
    • 11.3.4. Turkey Medical Biomimetics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Application
    • 11.3.5. Egypt Medical Biomimetics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Type
        • 11.3.5.2.2. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Wright Medical Group N.V.
  • 14.2. Abbott Laboratories, Inc.
  • 14.3. Blatchford Group (Chas. A. Blatchford & Sons Ltd)
  • 14.4. BioHorizons IPH, Inc.
  • 14.5. Biomimetics Technology Inc
  • 14.6. SynTouch Inc.
  • 14.7. Vandstrom, Inc.
  • 14.8. Gelesis, Inc.
  • 14.9. BioTomo Pty. Ltd.
  • 14.10. Hstar Technologies Corporation

15. Strategic Recommendations